Correlation Between Equillium and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Equillium and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and Inhibikase Therapeutics, you can compare the effects of market volatilities on Equillium and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Inhibikase Therapeutics.
Diversification Opportunities for Equillium and Inhibikase Therapeutics
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Equillium and Inhibikase is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Equillium i.e., Equillium and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Equillium and Inhibikase Therapeutics
Allowing for the 90-day total investment horizon Equillium is expected to generate 0.43 times more return on investment than Inhibikase Therapeutics. However, Equillium is 2.34 times less risky than Inhibikase Therapeutics. It trades about -0.23 of its potential returns per unit of risk. Inhibikase Therapeutics is currently generating about -0.32 per unit of risk. If you would invest 77.00 in Equillium on November 2, 2024 and sell it today you would lose (11.00) from holding Equillium or give up 14.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Equillium vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Equillium |
| Inhibikase Therapeutics |
Equillium and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Equillium and Inhibikase Therapeutics
The main advantage of trading using opposite Equillium and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |